About the Authors
- Fruzsina Soltész
-
* E-mail: fruzsina.x.soltesz@gsk.com (FS); pn254@cam.ac.uk (PN)
¶FS and JS are joint first authors on this work.
Affiliation Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, United Kingdom
- John Suckling
-
¶FS and JS are joint first authors on this work.
Affiliation Brain Mapping Unit, Department of Psychiatry, University of Cambridge, United Kingdom
- Phil Lawrence
-
Affiliation Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, United Kingdom
- Roger Tait
-
Affiliation Brain Mapping Unit, Department of Psychiatry, University of Cambridge, United Kingdom
- Cinly Ooi
-
Affiliation Brain Mapping Unit, Department of Psychiatry, University of Cambridge, United Kingdom
- Graham Bentley
-
Affiliation Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, United Kingdom
- Chris M. Dodds
-
Affiliation Department of Psychology, University of Exeter, Exeter, United Kingdom
- Sam R. Miller
-
Affiliation Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, United Kingdom
- David R. Wille
-
Affiliation Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, United Kingdom
- Misha Byrne
-
Affiliation Queensland Brain Institute, University of Queensland, Queensland, Australia
- Simon M. McHugh
-
Affiliation Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, United Kingdom
- Mark A. Bellgrove
-
Affiliation School of Psychology and Psychiatry, Monash University, Melbourne, Australia
- Rodney J. Croft
-
Affiliation Queensland Brain Institute, University of Queensland, Queensland, Australia
- Bai Lu
-
Affiliation Tsinghua University Medical School, Beijing, China
- Edward T. Bullmore
-
Affiliation Brain Mapping Unit, Department of Psychiatry, University of Cambridge, United Kingdom
- Pradeep J. Nathan
-
* E-mail: fruzsina.x.soltesz@gsk.com (FS); pn254@cam.ac.uk (PN)
Affiliations Brain Mapping Unit, Department of Psychiatry, University of Cambridge, United Kingdom, School of Psychology and Psychiatry, Monash University, Melbourne, Australia, New Medicines, UCB Pharma, Brussels, Belgium
Competing Interests
FS, PL, GB, SRM, DRW & SMH are employees of GlaxoSmithKline, whose company funded this study. PJN is an employee of UCB Pharma. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: PJN ETB BL. Performed the experiments: PL GB RT CO JS CMD. Analyzed the data: FS RT CO JS PL GB. Contributed reagents/materials/analysis tools: MAB MB RJC SM. Wrote the paper: FS PJN JS. statistical support and tools: SRM DRW.